750 related articles for article (PubMed ID: 8223747)
1. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
Kochs M; Eggeling T; Hombach V
Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
[TBL] [Abstract][Full Text] [Related]
2. Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.
Hilleman DE; Bauman AL
Pharmacotherapy; 2001 May; 21(5):556-75. PubMed ID: 11349745
[TBL] [Abstract][Full Text] [Related]
3. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
[TBL] [Abstract][Full Text] [Related]
4. Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction.
Singh BN
Am J Cardiol; 1990 Sep; 66(9):9C-20C. PubMed ID: 1699400
[TBL] [Abstract][Full Text] [Related]
5. Amiodarone: clinical trials.
Naccarelli GV; Wolbrette DL; Patel HM; Luck JC
Curr Opin Cardiol; 2000 Jan; 15(1):64-72. PubMed ID: 10666663
[TBL] [Abstract][Full Text] [Related]
6. Can antiarrhythmic drugs survive survival trials?
Pratt CM; Waldo AL; Camm AJ
Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
[TBL] [Abstract][Full Text] [Related]
7. Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists?
Stevenson WG; Ridker PM
JAMA; 1996 Aug; 276(6):481-5. PubMed ID: 8691557
[TBL] [Abstract][Full Text] [Related]
8. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
Lazzara R
Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326
[TBL] [Abstract][Full Text] [Related]
9. Arrhythmic risk stratification of post-myocardial infarction patients.
Naccarella F; Lepera G; Rolli A
Curr Opin Cardiol; 2000 Jan; 15(1):1-6. PubMed ID: 10666655
[TBL] [Abstract][Full Text] [Related]
10. Drugs or implantable cardioverter-defibrillators in patients with poor left ventricular function?
Block M; Hammel D; Böcker D; Borggrefe M; Breithardt G
Am J Cardiol; 1996 Sep; 78(5A):62-8. PubMed ID: 8820838
[TBL] [Abstract][Full Text] [Related]
11. [Antiarrhythmic therapy in patients with heart failure].
Faber TS; Zehender M
Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
[TBL] [Abstract][Full Text] [Related]
12. Non-arrhythmic therapy of ventricular tachyarrhythmias and sudden cardiac death after acute myocardial infarction.
Schweitzer P
Vnitr Lek; 2006 Dec; 52(12):1185-9. PubMed ID: 17299912
[TBL] [Abstract][Full Text] [Related]
13. [Sudden cardiac death--possibilities and limits of drug therapy].
Manz M; Lüderitz B
Z Kardiol; 1992 May; 81(5):237-45. PubMed ID: 1621403
[TBL] [Abstract][Full Text] [Related]
14. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
[TBL] [Abstract][Full Text] [Related]
15. Significance and control of cardiac arrhythmias in patients with congestive cardiac failure.
Singh BN
Heart Fail Rev; 2002 Jul; 7(3):285-300. PubMed ID: 12215733
[TBL] [Abstract][Full Text] [Related]
16. Prognosis and risk stratification after myocardial infarction.
Breithardt G; Borggrefe M; Fetsch T; Böcker D; Mäkijärvi M; Reinhardt L
Eur Heart J; 1995 Aug; 16 Suppl G():10-9. PubMed ID: 8595793
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G
Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989
[TBL] [Abstract][Full Text] [Related]
18. Electrocardiographic predictors in the ESVEM trial: unsustained ventricular tachycardia, heart period variability, and the signal-averaged electrocardiogram.
Anderson KP; Bigger JT; Freedman RA
Prog Cardiovasc Dis; 1996; 38(6):463-88. PubMed ID: 8638028
[TBL] [Abstract][Full Text] [Related]
19. Major clinical trials assessing the prophylactic use of amiodarone in patients with ventricular tachyarrhythmias.
Fogoros RN
Control Clin Trials; 1996 Jun; 17(3 Suppl):37S-46S. PubMed ID: 8877266
[TBL] [Abstract][Full Text] [Related]
20. [Ventricular tachyarrhythmia. Drug therapy and evaluation of success].
Seipel L; Kühlkamp V
Z Kardiol; 1993; 82 Suppl 5():155-61. PubMed ID: 8154157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]